APOE Genotype Effects on Alzheimer's Disease Onset and Epidemiology

2004/01/01 by J. Wesson Ashford · 1 citation
Medicine · #Alzheimer's disease #Alzheimer's disease research and treatments #Apolipoprotein E #Biology #Dementia and Cognitive Impairment Research #Disease #Epidemiology #Folate and B Vitamins Research #Gene #Genetic epidemiology #Genetics #Genotype #Internal medicine #Medicine #Neurology #Psychiatry

paper · doi:10.1385/jmn:23:3:157

crossref issued 2004/01/01 · crossref published 2004/01/01 · crossref published-online 2004/01/01 · openalex publication_date 2004/01/01 · crossref created 2004/06/04 · crossref deposited 2012/12/29 · openalex created_date 2016/06/24 · crossref indexed 2026/05/21 · openalex updated_date 2026/07/29

Citations

• “Mini-mental state”
• Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease
• Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families
• Apolipoprotein E isoforms and the development of low and high Braak stages of Alzheimer's disease-related lesions
• Modern human origins: progress and prospects
• Can an improved environment cause maximum lifespan to decrease? Comments on lifespan criteria and longitudinal Gompertzian analysis
• Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a ‘thrifty’ allele?
• Mild Cognitive Impairment
• The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects

Cited by

• Apolipoprotein E [wikipedia]